Riskpilot← Back to searchSign inGet full accessCarbozyme Oy
OYActiveY-tunnus 1568495-1Viirikuja 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 19992 employees
Revenue 2024
EUR 22K
+374% vs 2023
EBITDA margin
-543.3%
-125% vs 2023
Equity ratio
99.0%
Financial strength
Net profit 2024
EUR -154K
-61% vs 2023
| Revenue | EUR 22K | +374% |
| EBITDA | EUR -120K | -125% |
| Net profit | EUR -154K | -61% |
| Total assets | EUR 5,6M | -5% |
| Equity | EUR 5,5M | -6% |
| Employees | 2 | — |
Legal name
Carbozyme Oy
Y-tunnus number
1568495-1
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. joulukuuta 1999
Share capital
EUR 8 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on biotekniikan tuotteiden tuotto ja muokkaus sekä mainittuun toimintaan liittyvä myynti-, palvelu-, tutkimus-, koulutus-, maahantuonti- ja vientitoiminta. Yhtiö voi toimintaansa varten omistaa kiinteistöjä, osakkeita, arvopapereita ja yhtiöosuuksia.
Address
Viirikuja 8
Phone
+3580405703372
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 012 | 991 | 866 | 5 | 22 |
| Staff expenses | −30 | −48 | −76 | −74 | −75 |
| EBITDA | 958 | 906 | 735 | −53 | −120 |
| Depreciation & amort. | −31 | −30 | −29 | −29 | −65 |
| EBIT | 927 | 876 | 705 | −82 | −184 |
| Net financials | 146 | 292 | 40 | −14 | 30 |
| Profit before tax | 1 074 | 1 168 | 745 | −96 | −154 |
| Tax | 215 | 234 | 149 | −0 | −0 |
| Net profit | 859 | 934 | 596 | −96 | −154 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 978 | 5 754 | 6 140 | 5 885 | 5 562 |
| Equity | 4 888 | 5 672 | 6 098 | 5 832 | 5 508 |
| Long-term debt | 18 | 23 | 23 | 40 | 39 |
| Short-term debt | 72 | 59 | 19 | 14 | 15 |
| Total debt | 90 | 82 | 42 | 53 | 54 |
EBITDA margin
-543.3%
This company
15.8%
Market median
-3539% vs market
20202024
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-698.6%
This company
8.1%
Market median
-8725% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
OT Deputy Member | Deputy Member | 2019 |
FF Chief Executive Officer | Chief Executive Officer | 1999 |
| Former (2) | ||
JT | Audit | 2017 – 2023 |
AZ Deputy Member | Deputy Member | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Carbozyme Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jukka Tapani Hämäläinen | Audit | 0 companies |
| Antti-Jussi Zitting | Deputy Member | 0 companies |
| Olli Taneli Ruokolainen | Deputy Member | 0 companies |
| Fred Fenel | Chief Executive Officer | 0 companies |
| Kimmo Juhani Kohtamäki | Board of Directors | 0 companies |